Unusual association between autoimmune hepatitis and severe pyoderma gangrenosum

Journal of Pediatric Gastroenterology and Nutrition

Volumn 50, Issue 2, 2010, Pages 219-221

  Halac, Ugur ^a   Dhaybi, Rola Al ^a   Powell, Julie ^a   Soglio, Dorothée Bouron Dal ^b   Alvarez, Fernando ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CLOBETASOL PROPIONATE; CORTICOSTEROID; CYCLOSPORIN; INFLIXIMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; TRIAMCINOLONE;

ADOLESCENT; ARTICLE; AUTOIMMUNE HEPATITIS; CASE REPORT; DISEASE ASSOCIATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER FIBROSIS; LIVER NECROSIS; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; RASH; RECURRENCE RISK; REMISSION; SKIN BIOPSY; TREATMENT OUTCOME;

EID: 76349090927     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e31819a62f5     Document Type: Article

References (17)

1. Su WP, Davis MD, Weenig RH, et al. Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria [review]. Int J Dermatol 2004;43:790-800.
2. Powell FC, Schroeter AL, Su WP, et al. Pyoderma gangrenosum: a review of 86 patients. Q J Med 1985;55:173-186
3. Wollina U. Pyoderma gangrenosum-a review. Orphanet J Rare Dis 2007;2:19.
4. Bernstein CN, Blanchard JF, Rawsthorne P, et al. The prevalence of extraintestinal diseases in inflammatory bowel disease: a populationbased study. Am J Gastroenterol 2001;96:1116-1122
5. Stolman LP, Rosenthal D, Yaworsky R, et al. Pyoderma gangrenosum and rheumatoid arthritis. Arch Dermatol 1975;111:1020-1023
6. Török L, Kirschner A, Gurzó M, et al. Bullous pyoderma gangrenosum as a manifestation of leukemia cutis. Eur J Dermatol 2000;10:463-465
7. Wayte JA, Rogers S, Powell FC. Pyoderma gangrenosum, erythema elevatum diutinum and IgA monoclonal gammopathy. Australas J Dermatol 1995;36:21-23
8. Keane FM, MacFarlane CS, Munn SE, et al. Pyoderma gangrenosum and hepatitis C virus infection. Br J Dermatol 1998;139:924-925
9. Goldenberg G, Jorizzo JL. Use of etanercept in treatment of pyoderma gangrenosum in a patient with autoimmune hepatitis. J Dermatol Treat 2005;16:347-349
10. Koskinas J, Raptis I, Manika Z, et al. Overlapping syndrome of autoimmune hepatitis and primary sclerosing cholangitis associated with pyoderma gangrenosum and ulcerative colitis. Eur J Gastroenterol Hepatol 1999;11:1421-1424
11. Alvarez F, Ciocca M, Canero-Velasco R, et al. Short-term cyclosporine induces a remission of autoimmune hepatitis in children. J Hepatol 1999;30:222-227
12. Alvarez F. Autoimmune hepatitis and primary sclerosing cholangitis. Clin Liver Dis 2006;10:89-107.
13. Byrne JP, Hewitt M, Summerly R. Pyoderma gangrenosum associated with active chronic hepatitis: report of two cases. Arch Dermatol 1976;112:1297-1301
14. Burns DA, Sarkany I. Active chronic hepatitis and pyoderma gangrenosum: report of a case. Clin Exp Dermatol 1979;4:465-469
15. Ozorio G, McGarity B, Bak H, et al. Autoimmune hepatitis following infliximab therapy for ankylosing spondylitis. Med J Aust 2007; 187:524-526
16. Tobon G, Cañas C, Jaller JJ, et al. Serious liver disease induced by infliximab. Clin Rheumatol 2007;26:578-581
17. Everitt DE. Centocor. Important drug warning. Dec 2004 http://www. fda.gov/medwatch/Safety/2004 remicade-DHCP-dec04.pdf.